Cystatin C as a predictive marker of renal dysfunction and mid-term outcomes following off-pump coronary artery bypass grafting.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4602261)

Published in Heart on July 27, 2015

Authors

Seung Hyun Lee1, Young-Nam Youn1, Hyun Chel Choo1, Sak Lee1, Kyung-Jong Yoo1

Author Affiliations

1: Division of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University, College of Medicine, Yonsei University Health System, Seoul, Republic of Korea.

Articles cited by this

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58

A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol (2004) 4.32

Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation (2009) 3.75

Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol (2004) 3.63

Preoperative renal risk stratification. Circulation (1997) 3.47

Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int (1995) 2.97

Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg (2003) 2.96

Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA (2007) 2.89

Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. Ann Thorac Surg (2001) 2.32

Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg (1994) 2.05

Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant (2005) 1.72

Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int (2002) 1.61

Effect of diastolic dysfunction on early outcomes during elective off-pump coronary artery bypass grafting: a prospective observational study. Ann Thorac Surg (2011) 1.41

Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem (1999) 1.40

Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk-stratification algorithms. Kidney Int (2000) 1.32

Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol (2000) 1.24

Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem (2002) 1.20

Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. Am J Kidney Dis (2011) 1.17

Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol (2000) 1.17

Cystatin C: a promising marker and predictor of impaired renal function. Ann Clin Lab Sci (2006) 1.17

Neurological and cognitive disorders after coronary artery bypass grafting. Curr Opin Cardiol (2001) 1.06

Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron (2002) 1.06

Elimination of cardiopulmonary bypass improves early survival for multivessel coronary artery bypass patients. Ann Thorac Surg (2002) 1.01

Cystatin C measurement and its practical use in patients with various renal diseases. Clin Nephrol (1997) 0.96

Definition and classification of kidney diseases. Am J Kidney Dis (2013) 0.94

Cystatin C as a reliable marker of renal function following heart valve replacement surgery with cardiopulmonary bypass. Clin Chim Acta (2006) 0.93

Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study. Clin Chem (2011) 0.90

Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome. Atherosclerosis (2009) 0.89

Evaluation of Cystatin C as a marker of renal injury following on-pump and off-pump coronary surgery. Eur J Cardiothorac Surg (2005) 0.88

Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting. Ann Clin Biochem (2009) 0.83

Clinical value of cystatin C determination. Clin Chim Acta (2000) 0.83

Off-pump surgery and chronic renal insufficiency. Ann Thorac Surg (2000) 0.77